U.S. regulators have approved Pathway Medical Technology's first commercial product, a medical device that unclogs leg arteries, the Web...

Share story

U.S. regulators have approved Pathway Medical Technology’s first commercial product, a medical device that unclogs leg arteries, the Web site Xconomy reported today.

The product still won’t be available for sale because the Kirkland company has to create a sales team and build an inventory, Pathway executives told Xconomy.

In April, Pathway raised $24.5 million in venture capital from existing investors in anticipation of the U.S. Food and Drug Administration approval.